These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neural and molecular mechanisms in anxiety. Wolkowitz OM; Paul SM Psychiatr Clin North Am; 1985 Mar; 8(1):145-58. PubMed ID: 2859577 [TBL] [Abstract][Full Text] [Related]
3. Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety. Crespi F J Neurosci Methods; 2009 May; 180(1):97-105. PubMed ID: 19427535 [TBL] [Abstract][Full Text] [Related]
4. The present status of benzodiazepines in psychopharmacology. Iversen LL Arzneimittelforschung; 1980; 30(5a):907-10. PubMed ID: 6106495 [TBL] [Abstract][Full Text] [Related]
5. Clonidine and the primate locus coeruleus: evidence suggesting anxiolytic and anti-withdrawal effects. Redmond DE Prog Clin Biol Res; 1981; 71():147-63. PubMed ID: 6276892 [TBL] [Abstract][Full Text] [Related]
6. The primate locus coeruleus and effects of clonidine on opiate withdrawal. Redmond DE; Huang YH J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):25-9. PubMed ID: 6282817 [TBL] [Abstract][Full Text] [Related]
8. [The mechanism of action of benzodiazepine and its consequences for therapy]. Cugurra F Clin Ter; 1992 Apr; 140(4):331-43. PubMed ID: 1350239 [TBL] [Abstract][Full Text] [Related]
9. New molecular targets for antianxiety interventions. Gorman JM J Clin Psychiatry; 2003; 64 Suppl 3():28-35. PubMed ID: 12662131 [TBL] [Abstract][Full Text] [Related]
10. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety]. Ströhle A Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245 [TBL] [Abstract][Full Text] [Related]
11. [Functional aspects of the interaction between benzodiazepines and their central receptors]. Soubrié P Encephale; 1983; 9(4 Suppl 2):183B-190B. PubMed ID: 6327228 [TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of benzodiazepines. Stahmer SD S Afr Med J; 1985 Oct; Suppl():14-22. PubMed ID: 2865820 [TBL] [Abstract][Full Text] [Related]
13. Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs. Hayase T BMC Neurosci; 2007 Sep; 8():76. PubMed ID: 17877812 [TBL] [Abstract][Full Text] [Related]
14. GABA-A receptors and the response to CO(2) inhalation - a translational trans-species model of anxiety? Bailey JE; Nutt DJ Pharmacol Biochem Behav; 2008 Jul; 90(1):51-7. PubMed ID: 18485466 [TBL] [Abstract][Full Text] [Related]
15. [Peptides and anxiety]. Dantzer R Encephale; 1983; 9(4 Suppl 2):177B-182B. PubMed ID: 6144513 [TBL] [Abstract][Full Text] [Related]
16. Galanin-mediated anxiolytic effect in rat central amygdala is not a result of corelease from noradrenergic terminals. Barrera G; Hernandez A; Poulin JF; Laforest S; Drolet G; Morilak DA Synapse; 2006 Jan; 59(1):27-40. PubMed ID: 16237681 [TBL] [Abstract][Full Text] [Related]
17. [The functional role of monoaminergic and amino acid-ergic mechanisms of the locus coeruleus in anxiety from different aversive origins]. Talalaenko AN; Stakhovskiĭ IuV; Bogdanov BA; Babiĭ IuV; Perch NN Biull Eksp Biol Med; 1993 Jun; 115(6):634-6. PubMed ID: 8104050 [TBL] [Abstract][Full Text] [Related]
18. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Ressler KJ; Nemeroff CB Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410 [TBL] [Abstract][Full Text] [Related]